Breast Cancer News and Research

Latest Breast Cancer News and Research

BCA encourages people to urge KFC, Komen to to end "Buckets for the Cure" campaign

Breast Cancer Action -- respected watchdog of the breast cancer movement -- is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.

24 Apr 2010

McGill researchers receive $1.7M for 10 cutting-edge research projects

Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.

24 Apr 2010

Environmental factors may play bigger role in tumor development: BIDMC study

It is an accepted fact that genetics play a key role in a person's susceptibility to cancer, and that throughout life, mutations can cause damage to tumor suppressor genes further increasing the chances of developing cancerous tumors.

24 Apr 2010

Reuters: Wellpoint targets breast cancer patients for rescission

That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. ... And a congressional committee last year said WellPoint was one of the worst offenders.

24 Apr 2010

First Edition: April 23, 2010

Today's headlines focus on the new health laws coverage estimates, costs and impact on the health care system.

23 Apr 2010

Crystal structures of key fluorescent proteins to "light up" molecules in cells

Scientists at Albert Einstein College of Medicine of Yeshiva University have determined the crystal structures of two key fluorescent proteins - one blue, one red - used to "light up" molecules in cells.

23 Apr 2010

Pelosi responds to reports of WellPoint dropping coverage for breast cancer patients

"WellPoint's practice of dropping anyone's coverage when they get sick – whether a woman with breast cancer or any other patient – is exactly the kind of insurance company abuse our new health care law prohibits.

23 Apr 2010

Additional training may benefit physicians who interpret screening mammograms

A multi-site study led by an Oregon Health & Science University Knight Cancer Institute researcher has identified set criteria that could be used to help identify physicians who might benefit from additional training in interpreting screening mammograms.

23 Apr 2010

Funding levels need to be increased in fight against malaria

"To realize the real impact of investments in our fight against malaria, we must not only maintain current funding levels but actually increase them. If we don't, then the achievements we have made in providing malaria protection will be short lived," said Sunil Mehra, Executive Director of the UK-based Malaria Consortium.

23 Apr 2010

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Geron Corporation today announced five presentations by Geron scientists and collaborators on the company's telomerase inhibitor, imetelstat sodium, including the drug's activity against cancer stem cells, at the 101st American Association for Cancer Research annual meeting held in Washington D.C.

23 Apr 2010

Essilorl's first-quarter 2010 consolidated revenues up 7.8%

Essilor International, the world leader in ophthalmic optics, today announced that consolidated revenue for the three months ended March 31, 2010 rose by 7.8% to EUR905.8 million, in line with stated objectives.

23 Apr 2010

Detroit-area resident pleads guilty in fraudulent medical testing scheme

Detroit-area resident Melvin Young pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).

23 Apr 2010

Travel Toward Wellness specializes in women's wellness travel for cancer survivors

Cancer survivors often describe their experience as a "journey." Now Nancy Parker, veteran corporate executive and breast cancer survivor, is taking other survivors on a more joyful journey. Her company, Travel Toward Wellness, is filling a unique travel niche, specializing in girlfriend getaways and women's wellness travel for cancer survivors.

23 Apr 2010

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

Molecular biologist Alan Ashworth, Ph.D., FRS, the director of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London will receive the David T. Workman Memorial Award on May 17. The two-year grant of $50,000 from the Samuel Waxman Cancer Research Foundation will support Dr. Ashworth's work with PARP inhibitors in BRCA-mutated cancers.

23 Apr 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC

Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.

23 Apr 2010

Florida's Health Care Freedom Act receives approval

Today, Florida's Health Care Freedom Act (HJR 37/SJR 72), sponsored by Florida Representative Scott Plakon and Florida Senator Carey Baker, passed the House and Senate and will appear on the November ballot. And yesterday, Mississippi Representatives Alex Monsour and Steven Palazzo received preliminary approval to place the Health Care Freedom Act on the 2011 or 2012 ballot.

23 Apr 2010

Biological activity of Curis' CUDC-101 HDAC, EGFR and HER2 inhibitor published in Cancer Research

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a research paper describing the biological activity of its HDAC, EGFR and HER2 inhibitor, CUDC-101, was published online in the journal Cancer Research and also will be published in an upcoming print version of the journal.

23 Apr 2010

Report: Wellpoint targets breast cancer patients with policy rescissions

Reuters, in an exclusive report about the insurance industry practice of rescission: "That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. Insurance companies have used the practice.

23 Apr 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

BCA encourages people to urge KFC, Komen to to end "Buckets for the Cure" campaign

McGill researchers receive $1.7M for 10 cutting-edge research projects

Environmental factors may play bigger role in tumor development: BIDMC study

Reuters: Wellpoint targets breast cancer patients for rescission

First Edition: April 23, 2010

Crystal structures of key fluorescent proteins to "light up" molecules in cells

Pelosi responds to reports of WellPoint dropping coverage for breast cancer patients

Additional training may benefit physicians who interpret screening mammograms

Funding levels need to be increased in fight against malaria

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Essilorl's first-quarter 2010 consolidated revenues up 7.8%

Detroit-area resident pleads guilty in fraudulent medical testing scheme

Travel Toward Wellness specializes in women's wellness travel for cancer survivors

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC

Florida's Health Care Freedom Act receives approval

Biological activity of Curis' CUDC-101 HDAC, EGFR and HER2 inhibitor published in Cancer Research

Report: Wellpoint targets breast cancer patients with policy rescissions

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in